207 related articles for article (PubMed ID: 31428580)
1. The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond.
Onderdonk BE; Chmura SJ
Front Oncol; 2019; 9():706. PubMed ID: 31428580
[No Abstract] [Full Text] [Related]
2. The role of immunotherapy in combination with oligometastasis-directed therapy: a narrative review.
Turchan WT; Chmura SJ
Ann Palliat Med; 2021 May; 10(5):6028-6044. PubMed ID: 33440982
[TBL] [Abstract][Full Text] [Related]
3. Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer.
Wild AT; Yamada Y
Visc Med; 2017 Mar; 33(1):54-61. PubMed ID: 28612018
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Radiation for Oligometastatic and Oligoprogressive Stage IV Breast Cancer: A Case-Based Review.
Freedman GM; Jones JA; Taunk NK
Curr Oncol; 2023 Feb; 30(2):2510-2523. PubMed ID: 36826153
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.
Rogé M; Pointreau Y; Sargos P; Meyer E; Schick U; Hasbini A; Rio E; Bera G; Ruffier A; Quivrin M; Chasseray M; Latorzeff I; Martin E; Guimas V; Pommier P; Leroy T; Ronchin P; Lepinoy A; Grand A; Cartier L; Didas O; Denis F; Libois V; Blanc-Lapierre A; Supiot S
Clin Transl Radiat Oncol; 2023 May; 40():100613. PubMed ID: 36968576
[TBL] [Abstract][Full Text] [Related]
6. Oligometastases: history of a hypothesis.
Milano MT; Biswas T; Simone CB; Lo SS
Ann Palliat Med; 2021 May; 10(5):5923-5930. PubMed ID: 32279519
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach.
Sherwani Z; Parikh S; Yegya-Raman N; McKenna K; Deek M; Jabbour S; Hathout L
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444636
[TBL] [Abstract][Full Text] [Related]
8. Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer.
Niazi T; Elakshar S; Stroian G
Curr Opin Support Palliat Care; 2018 Sep; 12(3):351-358. PubMed ID: 29979320
[TBL] [Abstract][Full Text] [Related]
9. Modern evidence and future prospects of external body radiation therapy for lung oligometastases of breast cancer.
Wada Y; Hashimoto M
Transl Cancer Res; 2020 Aug; 9(8):5077-5086. PubMed ID: 35117873
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
Stefanovic M; Calvet G; Pérez-Montero H; Esteve A; Bujalance MV; Navarro-Martín A; Fernández MDA; González FF; Borras SM; Borbalas AL; Fernandez MN; Garau MM; Calduch AL; Edo FG
Clin Transl Oncol; 2023 Jan; 25(1):199-206. PubMed ID: 36068449
[TBL] [Abstract][Full Text] [Related]
11. Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification?
Franzese C; Badalamenti M; Comito T; Franceschini D; Clerici E; Navarria P; Loi M; D'agostino G; Baldaccini D; Chiola I; Reggiori G; Mancosu P; Tomatis S; Scorsetti M
Radiother Oncol; 2020 Sep; 150():184-190. PubMed ID: 32593644
[TBL] [Abstract][Full Text] [Related]
12. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
Robin TP; Raben D; Schefter TE
Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
Ahmed KA; Torres-Roca JF
Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
[TBL] [Abstract][Full Text] [Related]
14. SBRT for lung oligometastases: Who is the perfect candidate?
Navarria P; De Rose F; Ascolese AM
Rep Pract Oncol Radiother; 2015; 20(6):446-53. PubMed ID: 26696785
[TBL] [Abstract][Full Text] [Related]
15. Oligometastases in prostate cancer: Ablative treatment.
Palacios-Eito A; Béjar-Luque A; Rodríguez-Liñán M; García-Cabezas S
World J Clin Oncol; 2019 Feb; 10(2):38-51. PubMed ID: 30815370
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer.
Wujanto C; Vellayappan B; Siva S; Louie AV; Guckenberger M; Slotman BJ; Onishi H; Nagata Y; Liu M; Lo SS
Front Oncol; 2019; 9():1219. PubMed ID: 31799188
[TBL] [Abstract][Full Text] [Related]
17. Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases.
Conde-Moreno AJ; Lopez-Guerra JL; Macias VA; Vázquez de la Torre ML; Samper Ots P; San José-Maderuelo S; Pastor Peidro J; López-Torrecilla J; Expósito-Hernández J
Clin Transl Oncol; 2016 Apr; 18(4):342-51. PubMed ID: 26329294
[TBL] [Abstract][Full Text] [Related]
18. Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.
Battaglia A; De Meerleer G; Tosco L; Moris L; Van den Broeck T; Devos G; Everaerts W; Joniau S
Eur Urol Oncol; 2019 Mar; 2(2):174-188. PubMed ID: 31017094
[TBL] [Abstract][Full Text] [Related]
19. Long-Lasting Palliation of Bone Oligometastatic Prostate Cancer After Repeated Stereotactic Body Radiotherapy.
Maranzano E; Arcidiacono F; Casale M; Giannantoni A; Baffa N; Anselmo P; Marzo AD; Trippa F
Ochsner J; 2021; 21(3):301-305. PubMed ID: 34566514
[No Abstract] [Full Text] [Related]
20. Oligometastatic disease, the curative challenge in radiation oncology.
Palacios-Eito A; García-Cabezas S
World J Clin Oncol; 2015 Aug; 6(4):30-4. PubMed ID: 26266098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
